Radioactive Drug Research Committee #40 (RDRC #40)
The Radioactive Drug Research Committee (RDRC) is a subcommittee of the Emory University Radiation Safety Committee for Human Use (RSC I). The RDRC reviews certain research protocols involving radioactive compounds as required by FDA regulations (21 CFR 361.1). RSC I reviews all other human research protocols involving administration of radioactive materials or radiation from radioactive material to subjects solely as a result of participation in a research study. Specific information about the membership and meetings of the RDRC subcommittee can be found in Radiation Safety Committees document or on the EHSO Calendar, both linked below.